Argos Therapeutics Company
Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.
Technology:
Neurological Disorders
Industry:
PharmTech
Headquarters:
Durham, North Carolina, United States
Founded Date:
1997
Employees Number:
101-250
Funding Status:
IPO
Estimated Revenue:
$50M to $100M
Register and Claim Ownership